Optic
The AI engine Fit Assessment
BetaThe company effectively leverages machine learning to enhance drug discovery, identify novel candidates, and discover new patterns in molecular activity.
Blurb
Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.
HQ Location
San Francisco (United States)
Founded
2022
Employees
11 - 50
Total funding raised
$22.00M
Funding Status
Seed, $11.00M, July 20, 2022
Subspaces
- Drug Discovery Optimization
AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation. Automating biotech R&D.
About Optic
Optic started as an AI research team developing high-performance similarity search algorithms. Today our proprietary AI-technology is powering products in multiple industries from blockchain to biotech.